As of 2025-12-30, the Intrinsic Value of Elanco Animal Health Inc (ELAN) is 27.46 USD. This ELAN valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 22.65 USD, the upside of Elanco Animal Health Inc is 21.20%.
The range of the Intrinsic Value is 18.81 - 46.25 USD
Based on its market price of 22.65 USD and our intrinsic valuation, Elanco Animal Health Inc (ELAN) is undervalued by 21.20%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 18.81 - 46.25 | 27.46 | 21.2% |
| DCF (Growth 10y) | 21.21 - 46.96 | 29.38 | 29.7% |
| DCF (EBITDA 5y) | 26.91 - 31.72 | 30.72 | 35.6% |
| DCF (EBITDA 10y) | 28.29 - 34.79 | 32.66 | 44.2% |
| Fair Value | 0.36 - 0.36 | 0.36 | -98.40% |
| P/E | 1.42 - 21.02 | 10.96 | -51.6% |
| EV/EBITDA | 19.86 - 24.81 | 22.58 | -0.3% |
| EPV | 25.30 - 33.05 | 29.17 | 28.8% |
| DDM - Stable | 0.68 - 1.87 | 1.27 | -94.4% |
| DDM - Multi | 12.68 - 27.18 | 17.29 | -23.7% |
| Market Cap (mil) | 11,253.88 |
| Beta | 1.28 |
| Outstanding shares (mil) | 496.86 |
| Enterprise Value (mil) | 14,772.88 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.50% |
| Cost of Debt | 5.00% |
| WACC | 6.61% |